The impact of dilated left atrium on rhythm control in patients with newly diagnosed persistent atrial fibrillation: the Belgrade atrial fibrillation project. 2011

T S Potpara, and M M Polovina, and M M Licina, and N M Mujovic, and J M Marinkovic, and M Petrovic, and B Vujisic-Tesic, and G Y H Lip

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004554 Electric Countershock An electrical current applied to the HEART to terminate a CARDIAC ARRHYTHMIA. Cardiac Electroversion,Cardioversion,Defibrillation, Electric,Electroversion, Cardiac,Electrical Cardioversion,Electroversion Therapy,Therapy, Electroversion,Cardiac Electroversions,Cardioversion, Electrical,Cardioversions,Cardioversions, Electrical,Countershock, Electric,Countershocks, Electric,Defibrillations, Electric,Electric Countershocks,Electric Defibrillation,Electric Defibrillations,Electrical Cardioversions,Electroversion Therapies,Electroversions, Cardiac,Therapies, Electroversion
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000638 Amiodarone An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance. Amiobeta,Amiodarex,Amiodarona,Amiodarone Hydrochloride,Amiohexal,Aratac,Braxan,Corbionax,Cordarex,Cordarone,Kordaron,L-3428,Ortacrone,Rytmarone,SKF 33134-A,Tachydaron,Trangorex,Hydrochloride, Amiodarone,L 3428,L3428,SKF 33134 A,SKF 33134A
D000889 Anti-Arrhythmia Agents Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. Anti-Arrhythmia Agent,Anti-Arrhythmia Drug,Anti-Arrhythmic,Antiarrhythmia Agent,Antiarrhythmia Drug,Antiarrhythmic Drug,Antifibrillatory Agent,Antifibrillatory Agents,Cardiac Depressant,Cardiac Depressants,Myocardial Depressant,Myocardial Depressants,Anti-Arrhythmia Drugs,Anti-Arrhythmics,Antiarrhythmia Agents,Antiarrhythmia Drugs,Antiarrhythmic Drugs,Agent, Anti-Arrhythmia,Agent, Antiarrhythmia,Agent, Antifibrillatory,Agents, Anti-Arrhythmia,Agents, Antiarrhythmia,Agents, Antifibrillatory,Anti Arrhythmia Agent,Anti Arrhythmia Agents,Anti Arrhythmia Drug,Anti Arrhythmia Drugs,Anti Arrhythmic,Anti Arrhythmics,Depressant, Cardiac,Depressant, Myocardial,Depressants, Cardiac,Depressants, Myocardial,Drug, Anti-Arrhythmia,Drug, Antiarrhythmia,Drug, Antiarrhythmic,Drugs, Anti-Arrhythmia,Drugs, Antiarrhythmia,Drugs, Antiarrhythmic

Related Publications

T S Potpara, and M M Polovina, and M M Licina, and N M Mujovic, and J M Marinkovic, and M Petrovic, and B Vujisic-Tesic, and G Y H Lip
September 2023, HeartRhythm case reports,
T S Potpara, and M M Polovina, and M M Licina, and N M Mujovic, and J M Marinkovic, and M Petrovic, and B Vujisic-Tesic, and G Y H Lip
April 2015, Zhonghua yi xue za zhi,
T S Potpara, and M M Polovina, and M M Licina, and N M Mujovic, and J M Marinkovic, and M Petrovic, and B Vujisic-Tesic, and G Y H Lip
September 2022, Circulation,
T S Potpara, and M M Polovina, and M M Licina, and N M Mujovic, and J M Marinkovic, and M Petrovic, and B Vujisic-Tesic, and G Y H Lip
December 2023, International journal of cardiology. Heart & vasculature,
T S Potpara, and M M Polovina, and M M Licina, and N M Mujovic, and J M Marinkovic, and M Petrovic, and B Vujisic-Tesic, and G Y H Lip
December 2009, Pharmacotherapy,
T S Potpara, and M M Polovina, and M M Licina, and N M Mujovic, and J M Marinkovic, and M Petrovic, and B Vujisic-Tesic, and G Y H Lip
December 2022, American heart journal,
T S Potpara, and M M Polovina, and M M Licina, and N M Mujovic, and J M Marinkovic, and M Petrovic, and B Vujisic-Tesic, and G Y H Lip
April 2011, Cleveland Clinic journal of medicine,
T S Potpara, and M M Polovina, and M M Licina, and N M Mujovic, and J M Marinkovic, and M Petrovic, and B Vujisic-Tesic, and G Y H Lip
April 2022, Quantitative imaging in medicine and surgery,
T S Potpara, and M M Polovina, and M M Licina, and N M Mujovic, and J M Marinkovic, and M Petrovic, and B Vujisic-Tesic, and G Y H Lip
November 2021, Circulation,
T S Potpara, and M M Polovina, and M M Licina, and N M Mujovic, and J M Marinkovic, and M Petrovic, and B Vujisic-Tesic, and G Y H Lip
December 2003, QJM : monthly journal of the Association of Physicians,
Copied contents to your clipboard!